Revenue
136 thousand USD
2023 Q3 · USD
Exact inputs and evidence
- Revenue: 136310 USD Source
Market value is not computed: no listed ticker is recorded for this company.
25 filing records in this dataset, filed from 2022-03-09 to 2024-02-15. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
This issuer has insider filings in the store, but no transaction in this window or code group.
136 thousand USD
2023 Q3 · USD
-1,582.47%
2023 Q3 · %
-1.91 million USD
2023 Q3 · USD
-1.91 million USD
2023 Q3 · USD
1767870 USD
30737796 shares
84.57% · 14.1 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
1 million USD
2022-10-01 – 2023-09-30
-6.66 million USD
2022-10-01 – 2023-09-30
94 thousand USD
2022-10-01 – 2023-09-30
-6.76 million USD
2022-10-01 – 2023-09-30
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2024-02-15.
Financial data available through: 2022-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 319,832
–
Current period
USD 633,102
–
633102 − 319832 = 313270 USD
319832 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source633102 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 3.76 million
–
Current period
−USD 9.77 million
–
-9771770 − -3757949 = -6013821 USD
-3757949 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source-9771770 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 142,013
–
Current period
USD 28,607
–
28607 − 142013 = -113406 USD
142013 USD · 2021-01-01 – 2021-12-31
Inspect prior input Prior source28607 USD · 2022-01-01 – 2022-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Net income.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | 442919 | 2570439 Derived | -2127520 | Unavailable | Unavailable | -1816470 Derived | Source
|
| 2021 2021-01-01 – 2021-12-31 | 319832 | 5855460 Derived | -5535628 | Unavailable | Unavailable | -3899962 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 633102 | 12603117 Derived | -11970015 | Unavailable | Unavailable | -9800377 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Revenue | 442919 |
|
| 2021 | Revenue | 319832 |
|
| 2022 | Revenue | 633102 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | -27.8% |
|
| 2022 | Year over year | 97.9% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Operating margin | -480.3% |
|
| 2021 | Operating margin | -1,730.8% |
|
| 2022 | Operating margin | -1,890.7% |
|
| 2020-12-31 | Net margin | Not reported |
|
| 2021-12-31 | Net margin | Not reported |
|
| 2022-12-31 | Net margin | Not reported |
|
| 2020 | Free cash flow margin | -410.1% |
|
| 2021 | Free cash flow margin | -1,219.4% |
|
| 2022 | Free cash flow margin | -1,548% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Operating cash flow | -1804104 |
|
| 2021 | Operating cash flow | -3757949 |
|
| 2022 | Operating cash flow | -9771770 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Free cash flow | -1816470 |
|
| 2021 | Free cash flow | -3899962 |
|
| 2022 | Free cash flow | -9800377 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Liabilities / assets | 72.2% |
|
| 2021 | Liabilities / assets | 16.8% |
|
| 2022 | Liabilities / assets | 146.4% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Current assets / current liabilities | 1.33× |
|
| 2021 | Current assets / current liabilities | 6.49× |
|
| 2022 | Current assets / current liabilities | 0.61× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2020-01-01 – 2020-12-31 | Unavailable Not reported for this period. | −USD 1.8 million Exact valueExact value: -1804104 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 12,366 Exact valueExact value: 12366 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.82 million Calculation and evidence-1804104 − 12366 USD Exact free cash flow: -1816470 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | Unavailable Not reported for this period. | −USD 3.76 million Exact valueExact value: -3757949 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 142,013 Exact valueExact value: 142013 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 3.9 million Calculation and evidence-3757949 − 142013 USD Exact free cash flow: -3899962 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | Unavailable Not reported for this period. | −USD 9.77 million Exact valueExact value: -9771770 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 28,607 Exact valueExact value: 28607 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 9.8 million Calculation and evidence-9771770 − 28607 USD Exact free cash flow: -9800377 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
25 filings · 599 latest values · 599 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001907685, 1907685, edgar:1907685
Also known as COMERA LIFE SCIENCES HOLDINGS, INC., Comera Life Sciences Holdings, Inc.